Watch this video to understand the mechanism of action of antithrombin in thrombosis and why the administration of heparin only may not be sufficient to treat hereditary antithrombin deficiency but could also cause resistance in patients.
Clinical studies have shown that antithrombin is an effective choice for patients with hATd for the treatment and prevention of thromboembolism, including before, during, and after surgery and childbirth.
